Investors are eager for the Benchling IPO. The company made headlines when it confidentially filed with the SEC to go public. Biotechnology is rewriting life as we know it. Our customers, spanning ...

After collecting $300 million across two venture capital rounds last year, R&D cloud software developer Benchling is starting to spend some of that cash by making its first acquisition. The company ...

Benchling’s unicorn status didn’t come overnight. Some 10 years after its founding, the company is worth more than $6 billion, and the founder sees the company going public in the future. The ...

Sajith Wickramasekara, Benchling’s CEO and co-founder. Eight months after enabling its R&D cloud to support FDA-regulated work done in later stages of biopharma product development, Benchling has ...

Benchling is a next-gen laboratory informatics platform that is helping life science companies manage increasingly complex data workflows. GEN Edge talks to CEO/co-founder Saji Wickramasekara and ...